key: cord-0730592-zjbyevei
authors: Rutten, Jeanine J.S.; van Loon, Anouk M.; van Kooten, Janine; van Buul, Laura W.; Joling, Karlijn J.; Smalbrugge, Martin; Hertogh, Cees M.P.M.
title: Clinical Suspicion of COVID-19 in Nursing Home residents: symptoms and mortality risk factors
date: 2020-10-28
journal: J Am Med Dir Assoc
DOI: 10.1016/j.jamda.2020.10.034
sha: e9b4de3021fa054555c292e5fad92b268f97c58b
doc_id: 730592
cord_uid: zjbyevei

Objectives To describe symptomatology, mortality and risk factors for mortality in a large group of Dutch nursing home (NH) residents with clinically-suspected COVID-19 who were tested with a Reverse Transcription Polymerase Chain Reaction (RT-PCR) test. Design Prospective cohort study. Setting and participants Residents of Dutch NHs with clinically-suspected COVID-19 and who received RT-PCR test. Methods We collected data of NH residents with clinically-suspected COVID-19, via electronic health records between March 18th and May 13th, 2020. Registration was performed on diagnostic status (confirmed (COVID-19+)/ruled out (COVID-19-)) and symptomatology (typical and atypical symptoms). Information on mortality and risk factors for mortality were extracted from usual care data. Results In our sample of residents with clinically-suspected COVID-19 (N=4007), COVID-19 was confirmed in 1538 residents (38%). Although, symptomatology overlapped between residents with COVID-19+ and COVID-19-, those with COVID-19+ were three times more likely to die within 30 days (hazard ratio (HR), 3·1; 95% CI, 2·7 to 3·6). Within this group, mortality was higher for men than for women (HR, 1·8; 95%, 1·5-2·2) and we observed a higher mortality for residents with dementia, reduced kidney function, and Parkinson’s Disease, even when corrected for age, gender, and comorbidities. Conclusions and implications About 40% of the residents with clinically-suspected COVID-19 actually had COVID-19, based on the RT-PCR test. Despite an overlap in symptomatology, mortality rate was three times higher for residents with COVID-19+. This emphasizes the importance of using low-threshold testing in NH residents which is an essential prerequisite to using limited personal protective equipment and isolation measures efficiently.

likely to die within 30 days (hazard ratio (HR), 3·1; 95% CI, 2·7 to 3·6). Within this group, 23 mortality was higher for men than for women (HR, 1·8; 95%, 1·5-2·2) and we observed a 24 higher mortality for residents with dementia, reduced kidney function, and Parkinson's 25 Disease, even when corrected for age, gender, and comorbidities. 26 Conclusions and implications 27 About 40% of the residents with clinically-suspected COVID-19 actually had COVID-19, based 28 on the RT-PCR test. Despite an overlap in symptomatology, mortality rate was three times 29 higher for residents with COVID-19+. This emphasizes the importance of using low-threshold 30 testing in NH residents which is an essential prerequisite to using limited personal protective 31 equipment and isolation measures efficiently. It is evident that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acts 43 differently in older adults compared with younger adults. 4 First, older adults have been 44 reported to develop signs and symptoms more often, after being in contact with SARS-CoV-45 2. 4, 5 Next, there are also indications for atypical disease presentation in older adults with 46 symptoms such as delirium and falls 6-8 , and even for asymptomatic presentation 9 . In addition, shortness of breath and a high respiratory rate are reported to be more common in 48 older adults. 5 Indisputably, older age is associated with a higher mortality. 4, 5, [10] [11] [12] 49 accurate knowledge is lacking about the spectrum of symptomatology of 50 mortality and risk factors for mortality in NH residents. Furthermore, it is unknown to what 51 extent COVID-19 can be distinguished based on symptomatology from other infections (such 52 as influenza, other viruses and bacterial infections) in NH residents, and whether a RT-PCR 53 test is always necessary to make the distinction. Residents with a clinical suspicion of COVID-19 had a mean age of 84 years (SD: 9·8), were 149 mostly women (62%) and resided mostly on psychogeriatric wards (42%) ( Table 1) . Residents 150 with COVID-19+ were more likely to reside in a psychogeriatric ward (47% vs. 39%) and to 151 have dementia (62% vs. 51%) and were less likely to have chronic respiratory disease (21% 152 vs. 18%). Most residents with COVID-19+ had one (42%) or two (35%) typical symptoms (i.e., cough, 165 shortness of breath, fever); 9% did not have any typical symptoms. 166 Of the residents with COVID-19+, 63% presented with cough and 30% suffered from 167 shortness of breath (Table 2) . For residents where COVID-19 was ruled out this was 62% and 168 39%, respectively. Fever was more common in residents with COVID-19+ compared to 169 residents where COVID-19 was ruled out (63% vs. 42%), whereas shortness of breath and 170 sore throat were reported more frequently in residents with COVID-19-(39% vs. 30% and 171 13% vs. 10%). The risk of delirium/confusion/drowsiness and sore throat in residents with comparable to the incidence of these symptoms in residents with COVID-19-(29% and 10% 176 vs 27% and 13%) ( Table 2 ). Other symptoms, which could be outlined in an open text field, 177 were reported for 417 (27%) residents with COVID-19+ and for 869 (35%) of residents with COVID-19-. Fatigue was most commonly reported in residents with COVID-19+ (22%), 179 followed by diarrhea (18%), malaise (18%), rhinorrhea (12%), nausea/vomiting (12%), and 180 common cold (12%) ( Table 2) . Other symptoms such as headache and anosmia were 181 reported in less than 10% of cases. Fatigue and malaise were reported more often in 182 residents with COVID-19+ than in residents with COVID-19-(22% vs. 13% and 18% vs. 12%), 183 whereas nausea/vomiting was reported less often in residents with COVID-19+ (12% vs. vs. 25 days (IQR = 9) for women with COVID-19. We found an HR of 1·8; 95% CI, 1·6 to 2·2; 214 P<0·001 when adjusted for age and comorbidities (see Figure 1B ). delirium/ confusion/drowsiness, fatigue, diarrhea, malaise, rhinorrhea, nausea/vomiting, 227 and common cold). We observed an overlap in symptoms between residents with and 228 without confirmed COVID-19 following clinically-suspected COVID-19. However, fever 229 occurred more frequent in the COVID-19 confirmed group (63% versus 42%). Furthermore, 230 the mortality rate in residents with confirmed COVID-19 was three times higher than in 231 residents where COVID-19 was ruled out. For residents with confirmed COVID-19, the 30-day 232 mortality in men was higher than in women. In addition, dementia, reduced kidney function, 233 and Parkinson's disease were all associated with a higher mortality rate in residents with 234 confirmed COVID-19, even when corrected for age, gender, and comorbidities. 235 236 In our sample, 63% of the NH residents with confirmed COVID-19 presented with fever, 63% 237 with cough and 30% with shortness of breath. This is in line with a previous study that 238 showed that fever (75%) was most common in older adults, followed by cough (44%) and 239 shortness of breath (25%). 11 In contrast, another study in older people showed that cough 240 (80%) was more common than fever (60%). 15 However, the sample sizes of the age groups (> 241 80 years) was much smaller in both studies (N = 16 and N = 20) . Our study showed that 242 COVID-19 in NH residents presents itself with both typical and atypical symptoms. We observed that in residents with confirmed COVID-19, men were more likely to die than 255 women. This difference in mortality has also been found in other studies on COVID-19, 10, 18 256 and preliminary data indicate an association between comorbidities, such as cardiovascular 257 disease, and severity of COVID-19. 5, 19 However, we adjusted our survival analyses for 258 comorbidities, yet the difference in mortality between men and women remained. It has 259 been suggested that this gender difference might be related to gender differences in SARS- 260 CoV-2 entry receptors. 20 Nonetheless, it remains unclear whether increased mortality for 261 men is specific to COVID-19. In general, men are sick more often and more severely sick due 262 to gender differences in hormones, immune responses and immune aging, and gender-263 specific differences in lifestyle and health behavior. 21 Therefore, the observed difference in 264 COVID-19 mortality between men and woman may be explained by the men-women 265 disability survival paradox. 22 This is the phenomenon that higher life expectancy is 266 accompanied by higher rates of disability in women compared with men, but disability 267 increases risk of mortality more in men than women. Therefore, men might be less resilient 268 to acute infectious diseases as COVID-19. 23 In contrast to our study, they also found an association between diabetes 275 mellitus, cardiovascular-, neurological-, and respiratory diseases and mortality. Prior to our 276 study, PD had been suggested as a comorbid risk factor for COVID-19 mortality, but empirical 277 data was lacking. 24 We show, for the first time in a large study population, that PD increased 278 mortality risk of COVID-19 in NH residents. One possibility for this is an increased chance of 279 death arising from pneumonia in PD patients, 24, 25 although further data is required to test residents who met the criteria as described in the Verenso guidelines (i.e. residents with 300 fever, cough, or shortness of breath) were tested. As a result, we were not able to describe 301 the occurrence of an atypical or asymptomatic presentation of COVID-19 properly. A study in 302 American NH residents found that almost half of residents with COVID-19 were 303 asymptomatic at the time of testing, but developed symptoms later. 9 304 305

In a large cohort of clinically-suspected COVID-19 NH residents, 38% of the residents with 307 clinically-suspected COVID-19 actually had a confirmed COVID-19. There was an overlap in 308 symptoms between residents with confirmed COVID-19 and those for whom COVID-19 was 309 ruled out, but we found that mortality rate in residents with confirmed COVID-19 was three 310 times higher. This emphasizes the importance of using a low threshold to test NH residents 311 for SARS-CoV-2. This is of vital importance since detecting positive COVID-19 diagnoses in 312 NHs is extremely important, and an essential prerequisite to using limited personal 313 protective equipment and quarantine and isolation measures efficiently. Furthermore, our 314 data demonstrated that COVID-19 affects male residents disproportionally, mortality was 315 almost twice as high for men than for women. It has been suggested that gender-differences 316 in comorbidity could explain this effect. However, our data demonstrates that the increased 317 mortality risk for men remained even when corrected for age and comorbidities. J o u r n a l P r e -p r o o f 

RIVM. Patiënt met nieuw coronavirus in Nederland

The impact of COVID-19 on long-term care in the Netherlands

International Long-Term Care Policy Network, CPEC-LSE

Excess mortality caused by novel coronavirus (Covid-19)

Aantal bewoners van verzorgings en verpleeghuizen 2019. 347 14. Verenso

Clinical Characteristics of Elderly Patients with COVID-19 in 349

Epidemiology of Covid-19 in a Long-Term Care 351 Facility in King County

We thank the facility residents; the physicians who work in the long-term care facilities for their time to fill in the COVID-19 registration and their ongoing efforts to provide care in the face of these challenges; Prof. Dr. Jos

Twisk and Dr. Birgit Lissenberg-Witte for their help with the survival analyses Dr. James Kirkbride for proofreading our manuscript and the staff of Gerimedica for their support.